Recombinant SARS-CoV-2 Vaccine (CHO Cell)

recombinant SARS-CoV-2 vaccine produced in CHO cells · National Vaccine and Serum Institute, China

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant SARS-CoV-2 Vaccine (CHO Cell), covering 2026-01-16 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19 [Phase 1, Phase 2]